Kestra Medical Technologies, Ltd. (KMTS)
NASDAQ: KMTS · Real-Time Price · USD
21.57
+0.68 (3.26%)
Jul 23, 2026, 4:00 PM EDT - Market closed

KMTS Stock Forecast

Stock Price Forecast

According to 7 analysts polled by S&P Global, KMTS stock has a consensus rating of "Strong Buy" and an average price target of $30. The average 1-year stock price forecast is 39.08% higher than the current stock price, while the lowest is $28 (+29.81%) and the highest is $32 (+48.35%).

Price Target: $30 (+39.08%)
Analyst Consensus: Strong Buy

Price Target

Chart
TargetLowAverageMedianHigh
Price$28$30$30$32
Change+29.81%+39.08%+39.08%+48.35%

Analyst Ratings

The average analyst rating for KMTS stock is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.

Recommendation Trends

Chart
RatingDec '25Jan '26Mar '26Apr '26May '26Jul '26
Strong Buy555555
Buy111111
Hold111111
Sell000000
Strong Sell000000
Total777777

Latest Forecasts

AnalystFirmRatingRatingActionPrice TargetUpsideDate
Piper Sandler
Piper Sandler
Buy
Maintains
$30
BuyMaintains$30+39.08%Jul 15, 2026
Stifel Nicolaus
Stifel Nicolaus
Buy
Maintains
$30
BuyMaintains$30+39.08%Jul 15, 2026
Bank of America Securities
Bank of America Securities
Buy
Reiterates
$30
BuyReiterates$30+39.08%Jul 15, 2026
BTIG
BTIG
Buy
Reiterates
$30$32
BuyReiterates$30$32+48.35%Jul 15, 2026
Wells Fargo
Wells Fargo
Buy
Reiterates
$28
BuyReiterates$28+29.81%Jul 15, 2026
More Analyst Ratings

Financial Forecast

Revenue This Year
136.99M
from 95.13M
Increased by 44.01%
Revenue Next Year
194.57M
from 136.99M
Increased by 42.03%
EPS This Year
-2.31
from -1.71
EPS Next Year
-2.02
from -2.31
Fiscal YearFY 2021FY 2023FY 2024FY 2025FY 2026FY 2027
Period EndingApr 30, 2021Apr 30, 2023Apr 30, 2024Apr 30, 2025Apr 30, 2026Apr 30, 2027
Revenue
-7.63M27.81M59.82M95.13M136.99M
Revenue Growth
--264.54%115.05%59.03%44.01%
Gross Profit
--10.65M362.00K24.21M48.86M80.14M
Gross Margin
--139.59%1.30%40.47%51.37%58.50%
Operating Income
-32.71M-80.42M-85.06M-106.38M-134.74M-135.17M
Net Income
-34.10M-84.24M-94.12M-113.81M-131.61M-136.49M
EPS
-----1.71-2.31
Free Cash Flow
-18.53M--40.92M-67.53M-75.76M-116.45M
No. Analysts
-----6
EPS and Forward PE are based on non-GAAP adjusted numbers.

Revenue Forecast

Revenue202720282029
High137.1M
Avg137.0M
Low136.9M

Revenue Growth

Revenue Growth202720282029
High
44.1%
Avg
44.0%
Low
43.9%

EPS Forecast

EPS202720282029
High-2.28
Avg-2.31
Low-2.33

EPS Growth

EPS Growth202720282029
High-
Avg-
Low-